Kardigan, Inc. (KARD)
21.92
+2.32
(+11.84%)
USD |
NASDAQ |
Sep 02, 16:00
21.88
-0.04
(-0.18%)
After-Hours: 20:00
Kardigan EPS Diluted (Quarterly) : -1.244 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.244 |
| March 31, 2026 | -0.6276 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.643 |
| March 31, 2025 | -0.2017 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.268 |
| Bristol Myers Squibb Co. | 1.620 |
| Crinetics Pharmaceuticals, Inc. | -1.145 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -116.24M |
| Total Expenses (Quarterly) | 116.24M |
| Enterprise Value | 1.465B |
| Earnings Yield | -12.39% |
| Normalized Earnings Yield | -10.76 |